Cardiac resynchronization therapy upregulates cardiac autonomic control

Journal of Cardiovascular Electrophysiology

Volumn 19, Issue 10, 2008, Pages 1045-1052

  Cha, Yong Mei ^a,c   Oh, Jae ^a   Miyazaki, Chinami ^a   Hayes, David L ^a   Rea, Robert F ^a   Shen, Win Kuang ^a   Asirvatham, Samuel J ^a   Kemp, Brad J ^a   Hodge, David O ^a   Chen, Peng Sheng ^b   Chareonthaitawee, Panithaya ^a  

^a Mayo Clinic   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Mary Brigh Building 4 523 ^*  (United States)

Author keywords

123iodine metaiodobenzylguanidine; Cardiac resynchronization therapy; Cardiomyopathy; Heart failure; Sympathetic nerve; Ventricular dyssynchrony

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY MONITORING; FEMALE; FOLLOW UP; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART RATE VARIABILITY; HEART SCINTISCANNING; HUMAN; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; SYMPATHETIC FUNCTION;

3-IODOBENZYLGUANIDINE; AGED; AUTONOMIC NERVOUS SYSTEM; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY, AMBULATORY; FEEDBACK; FEMALE; HEART FAILURE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; RADIOPHARMACEUTICALS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 52049108014     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2008.01190.x     Document Type: Article

References (42)

1. Liang C, Fan T, Sullegarger J, Sakamoto S : Decreased adrenergic neuronal uptake activity experimental right heart failure. A chamber-specific contributor to beta-adrenoceptor down regulation. J Clin Invest 1989 84 : 1267 1275.
2. Himura T, Felten S, Kashiki M, Lewandowski T, Delenhanty J, Liang C : Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure. Circulation 1993 88 : 1299 1309.
3. Zucker I, Wang W, Pliquett R, Lie J, Patel K : The regulation of sympathetic outflow in heart failure. The roles of angiotensin II, nitric oxide, and exercise training. Ann N Y Acad Sci 2001 940 : 431 443.
4. Lombardi F, Porta A, Marzegalli M, Favale S, Santini M, Vicenti A, De Rosa A : Heart rate variability patterns before ventricular tachycardia onset in patients with an implantable cardioverter defibrillator. Participating investigators of ICD-HRV Italian Study Group. Am J Cardiol 2000 86 : 959 963.
5. Meredith I, Broughton A, Jennings G, Esler M : Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 1991 325 : 618 624.
6. Packer M, Coats A, Fowler M, Katus H, Krum H, Mohacsi P, Rouleau J, Tendera M, Castaigne A, Roecker E, Schultz M, DeMets D : Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001 344 : 1651 1658.
7. SOLVD : Effect of further enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991 325 : 293 302.
8. Abraham W, Fisher W, Smith A, Delurgio D, Leon A, Loh E, Kocovic D, Packer M, Clavell A, Hayes D, Ellestad M, Trupp R, Underwood J, Pickering F, Truex C, McAtee P, Messenger J : Cardiac resynchronization in chronic heart failure. N Engl J Med 2002 346 : 1845 1853.
9. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood G, Santini M, Bailleul C, Daubert J : Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001 344 : 873 880.
10. Young J, Abraham W, Smith A, Leon A, Lieberman R, Wilkoff B, Canby R, Schroeder J, Liem L, Hall S, Wheelan K : Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003 289 : 2685 2694.
11. Cleland G, Daubert J, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L : The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005 352 : 1539 1549.
12. Adamson P, Kleckner K, VanHout W, Srinivasan S, Abraham W : Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 2003 108 : 266 269.
13. Sisson J, Wieland D, Sherman P, Mangner T, Tobes M, Jacques S : Metaiodobenzylguandidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987 28 : 1620 1624.
14. Wieland D, Brown L, Rogers W, Worthington K, Wu J, Clinthorne N, Otto C, Swanson D, Beierwaltes W : Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 1981 22 : 22 31.
15. Electrophysiology TFotESoCtNASoPa : Heart rate variability: Standards of measurement, physiological interpretation, and clinical use. Circulation 1996 93 : 1043 1065.
16. Somsen G, Verberne H, Fleury E, Righetti A : Normal values and withing-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: Implications for clinical studies. J Nucl Cardiol 2004 11 : 126 133.
17. Oh J, Seward J, Tajik A : The Echo Manual, 2nd edition. Philadelphia, PA : Lippincott Williams & Wilkins, 1999.
18. Association AH : American Heart Association 2002 Heart and Stroke Statistical Update. Dallas, TX : American Heart Association, 2002.
19. Cohn J, Levine T, Olivari M, Garberg V, Lura D, Francis G, Simon A, Rector T : Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984 311 : 819 823.
20. Kaye D, Lefkovits J, Jennings G, Bergin P, Brouthton A, Esler M : Adverse consequences of high sympathetic nervous activity in the failing human heart. JACC 1995 26 : 1257 1263.
21. Packer M : The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure. JACC 1992 20 : 248 254.
22. Yamada T, Shimonagata T, Fukunami M, Kumagai K, Ogita H, Hirata A, Asai M, Makino N, Kioka H, Kusuoka H, Hori M, Hoki N : Comparison of the prognositc value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: A prospective study. JACC 2003 41 : 231 238.
23. Inamura Y, Ando H, Mitsuoka W, Egashira S, Masaki H, Ashihara T, Fukuyama T : Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. JACC 1995 26 : 1594 1599.
24. Ogita H, Shimonagata T, Fukunami M, Yamada T, Asano Y, Hirata A, Asai M, Kusuoka H, Hori M, Hoki N : Prognostic significance of cardiac (123) I metaiodobenzylguandidine imaging for mortality and morbidity in patients with chronic heart failure: A prospective study. Heart 2001 86 : 656 660.
25. Nolan J, Batin P, Andrews R, Lindsay S, Brooksby P, Mullen M, Baig W, Flapan A, Cowley A, Prescott R, Neilson J, Fox K : Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998 98 : 1510 1560.
26. LA Rovere M, Pinna G, Maestri R, Mortara A, Capomolla S, Febo O, Ferrari R, Franchini M, Gnemmi M, Opasich C, Riccardia P, Traversi E, Cobelli F : Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003 107 : 565 570.
27. Stellbrink C, Breithardt O, Franke A, Sack S, Bakker P, Auricchio A, Pochet T, Salo R, Kramer A, Spinelli J : Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol 2001 38 : 1957 1965.
28. Liang C, Yatani A, Himura Y, Kashiki M, Stevens S : Desipramine attenuates loss of cardiac sympathetic neurotransmitters produced by congestive heart failure and NE infusion. Am J Physiol-Heart Circ Physiol 2003 284 : H1729 H1736.
29. Cha Y, Redfield M, Shah S, Shen W, Fishbein M, Chen P : Effects of omapatrilat on cardiac nerve sprouting and structural remodeling in experimental congestive heart failure. Heart Rhythm 2005 2 : 984 990.
30. Toyama T, Hoshizaki H, Seki R, Isobe N, Adachi H, Naito S, Oshima S, Taniguchi K : Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: Comparison with metoprolol therapy. J Nucl Med 2003 44 : 1604 1611.
31. Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Susuki T, Kurabayashi M : Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure. J Nucl Med 2003 44 : 884 890.
32. Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M : Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure. J Nucl Med 2002 43 : 1279 1285.
33. Latini R, Masson S, Anand I, Judd D, Maggioni A, Shiang Y, Bevilacqua M, Salio M, Cardano P, Dunselman P, Holwerda N, Tognoni G, Cohn J : Effects of Valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: The Valsartan heart failure trial (Val-HeFT). Circulation 2002 106 : 2454 2458.
34. Azevedo E, Kubo T, Mak S, Al-Hesayen A, Schofield A, Allan R, Kelly S, Newton G, Floras J, Parker J : Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: Differential effects on sympathetic activity. Circulation 2001 104 : 2194 2199.
35. Adamson P, Kleckner K, Warren L, Srinivasan S, Abraham W : Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 2003 108 : 266 269.
36. Braun M, Rauwolf T, Zerm T, Schulze M, Schnabel A, Strasser R : Long term biventricular resynchronisation therapy in advanced heart failure: Effect on neurohormones. Heart 2004 91 : 601 605.
37. Boriani G, Regoli F, Saporito D, Martignani C, Toselli T, Biffi M, Francolini G, Diemberger I, Bacchi L, Rapezzi C, Ferrari R, Branzi A : Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response. Peptides 2006 27 : 1776 1786.
38. Seifert M, Schlegl M, Hoersch W, Fleck E, Doelger A, Stockburger M, Butter C : Functional capacity and changes in the neurohormonal and cytokine status after long-term CRT in heart failure patients. Int J Cardiol 2007 121 : 68 73.
39. Saxon L : TEE evidence of right atrial tachycardia with mechanical alternans, interatrial and atrioventricular 2:1 block. Pacing Clin Electrophysiol 1999 Abstract) : 829 830.
40. Grassi G, Vincenti A, Brambilla R, Trevano F, Dell'Oro R, Ciro A, Trocino G, Vincenzi A, Mancia G : Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure. Hypertension 2004 44 : 727 731.
41. Hamdan M, Jason M, Zagrodzky J, Joglar J, Sheehan C, Ramaswamy K, Erdner J, Page R, Smith M : Biventricular pacing decreases sympathetic activity compared with right ventricular pacing in patients with depressed ejection fraction. Circulation 2000 102 : 1027 1032.
42. Toyama T, Hoshizaki H, Seki R, Isobe N, Adachi H, Naito S, Oshima S, Taniguchi K : Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: Comparison with metoprolol therapy. J Nucl Cardiol 2003 44 : 1604 1611.